On September 23rd, T1D Exchange held our 2019 Annual Meeting, focused on our continued efforts to utilize data and collaboration to improve outcomes for individuals with type 1 diabetes. Key industry leaders convened in Boston to hear representatives from the U.S. Food and Drug Administration speak on the importance of using real-world evidence in drug and device development.
We also heard from participants of the T1D Exchange Quality Improvement Collaborative who discussed the ways in which we are capturing and utilizing real-world evidence to guide clinic decision-making and interventions to improve the lives of our patients.
If you were not able to join us or would like to look back on the day’s activities, please view the digital booklet we’ve created for you.
Visit https://t1dexchange.org/annual-meeting-recap-2019/ to download today.